The emergence of powerful oral anti-COVID-19 drugs in the post-vaccine era
Lancet Microbe
.
2022 Feb;3(2):e91.
doi: 10.1016/S2666-5247(21)00278-0.
Epub 2021 Nov 25.
Authors
Huahao Fan
1
,
Fuxing Lou
1
,
Junfen Fan
2
,
Maochen Li
1
,
Yigang Tong
1
Affiliations
1
College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China.
2
Institute of Cerebrovascular Disease Research and Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China.
PMID:
34849495
PMCID:
PMC8616564
DOI:
10.1016/S2666-5247(21)00278-0
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
COVID-19*
Humans
SARS-CoV-2
Vaccines*
Substances
Vaccines